R. Haynes

Results of a completed phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine.

S. Libutti, M. Walker, G. Paciotti, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preliminary results of a phase I clinical trial of CYT-6091: A pegylated colloidal gold-TNF nanomedicine

S. Libutti, G. Paciotti, L. Myer, 2007 .

Coselection for resistance to multiple late‐generation human therapeutic antibiotics encoded on tetracycline resistance plasmids captured from uncultivated stream and soil bacteria

J. B. Herrick, R. Haynes, S. Heringa, 2014, Journal of applied microbiology.